Follow the 아이엠비디엑스 share price and the full management transaction log of the company, a listed equity based in South Korea. Shares are listed on KR KR, under the oversight of DART (FSS). Operating in the Health Care sector, 아이엠비디엑스 has published 25 insider filings. The latest transaction was filed on 9 July 2026 (Purchase). Among the most active insiders: 김태유. The full history is openly available.
25
Insider Decl.
n/a
Thresholds
n/a
21 ops.
Buy Volume
n/a
4 ops.
Sell Volume
5Σ signal
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Σ
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI-generated analysis. Opinion, not investment advice. Not backtested. Built from public filings and financials. No price target, no buy or sell recommendation.
아이엠비디엑스 is a healthcare and pharmaceutical company listed on the XKRX market. It focuses on developing innovative solutions in the pharmaceutical field.